Royal Bank Of Canada Novavax Inc Transaction History

Royal Bank Of Canada

$425 Billion
Q2 2024

A detailed history of Royal Bank Of Canada transactions in Novavax Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 23,690 shares of NVAX stock, worth $322,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,690

Previous 62,572 62.14%

Holding current value

$322,420

Previous $299,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $151,250 - $815,355	-38,882 Reduced 62.14%	23,690 $299,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $72,853 - $116,643	19,376 Added 44.86%	62,572 $299,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $83,222 - $132,982	17,338 Added 67.05%	43,196 $207,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $40,832 - $58,401	5,996 Added 30.19%	25,858 $187,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $32,896 - $46,952	4,932 Added 33.03%	19,862 $147,000
Q1 2023 May 15, 2023	SELL	$5.76 - $12.48 $76,406 - $165,547	-13,265 Reduced 47.05%	14,930 $103,000
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $103,148 - $291,515	-11,642 Reduced 29.22%	28,195 $289,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $882,263 - $3.69 Million	-48,476 Reduced 54.89%	39,837 $726,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $1.78 Million - $3.7 Million	-49,186 Reduced 35.77%	88,313 $4.54 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $3.07 Million - $6.28 Million	43,957 Added 46.99%	137,499 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $3.19 Million - $5.16 Million	23,690 Added 33.91%	93,542 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $4.75 Million - $7.23 Million	26,716 Added 61.93%	69,852 $14.5 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $5.22 Million - $11.1 Million	43,136 New	43,136 $9.16 Million

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.06B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Novavax Inc Transaction History